What is the share price of Nureca Ltd (NURECA) today?
The share price of NURECA as on 10th July 2025 is ₹289.90. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Nureca Ltd (NURECA) share?
The past returns of Nureca Ltd (NURECA) share are- Past 1 week: 6.62%
- Past 1 month: 3.86%
- Past 3 months: 39.38%
- Past 6 months: -23.85%
- Past 1 year: 4.58%
- Past 3 years: -70.92%
- Past 5 years: -55.11%
What are the peers or stocks similar to Nureca Ltd (NURECA)?
The peers or stocks similar to Nureca Ltd (NURECA) include:What is the market cap of Nureca Ltd (NURECA) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Nureca Ltd (NURECA) is ₹299.66 Cr as of 10th July 2025.What is the 52 week high and low of Nureca Ltd (NURECA) share?
The 52-week high of Nureca Ltd (NURECA) is ₹447.50 and the 52-week low is ₹203.62.What is the PE and PB ratio of Nureca Ltd (NURECA) stock?
The P/E (price-to-earnings) ratio of Nureca Ltd (NURECA) is 348.44. The P/B (price-to-book) ratio is 1.54.Which sector does Nureca Ltd (NURECA) belong to?
Nureca Ltd (NURECA) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Nureca Ltd (NURECA) shares?
You can directly buy Nureca Ltd (NURECA) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Nureca Ltd
NURECA Share Price
289.903.25% (-9.75)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
NURECA Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
NURECA Performance & Key Metrics
NURECA Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 369.94 | 1.54 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.77 | 6.43 | 0.79% |
NURECA Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
NURECA Company Profile
Nureca Ltd is engaged in the marketing of home healthcare & wellness products
SUNPHARMA
PE Ratio
36.65
36.65
1Y Return
4.00%
4.00%
Buy Reco %
87.50
87.50
CIPLA
PE Ratio
22.85
22.85
1Y Return
2.34%
2.34%
Buy Reco %
73.33
73.33
TORNTPHARM
PE Ratio
59.39
59.39
1Y Return
13.13%
13.13%
Buy Reco %
70.83
70.83
DRREDDY
PE Ratio
18.68
18.68
1Y Return
4.24%
4.24%
Buy Reco %
51.72
51.72
MANKIND
PE Ratio
52.37
52.37
1Y Return
18.31%
18.31%
Buy Reco %
81.25
81.25
NURECA Forecast
NURECA Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
NURECA
NURECA
Income
Balance Sheet
Cash Flow
Annual Normal View
NURECA Income Statement
NURECA Income Statement
Annual Normal View
| Financial Year | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 20.07 | 61.99 | 99.49 | 216.27 | 263.25 | 118.43 | 102.44 | 122.10 | 122.09 | |||||||||
Raw Materials | 15.68 | 50.16 | 67.49 | 120.01 | 159.55 | 44.76 | 56.23 | 74.97 | 117.21 | |||||||||
| Power & Fuel Cost | 0.02 | 0.04 | 0.01 | 0.16 | 0.20 | 0.13 | 0.18 | |||||||||||
| Employee Cost | 0.89 | 3.16 | 4.58 | 9.91 | 16.06 | 12.20 | 15.31 | |||||||||||
| Selling & Administrative Expenses | 11.12 | 19.66 | 44.81 | 51.71 | 30.34 | 24.91 | 30.25 | |||||||||||
| Operating & Other expenses | -9.35 | -0.61 | -17.50 | -21.29 | 34.97 | 8.67 | -3.51 | |||||||||||
EBITDA | 4.39 | 9.15 | 9.75 | 64.36 | 63.21 | -7.90 | 0.30 | 4.90 | 4.88 | |||||||||
| Depreciation/Amortization | 0.01 | 0.06 | 0.37 | 0.42 | 1.48 | 2.39 | 2.36 | 2.34 | 2.34 | |||||||||
| PBIT | 4.38 | 9.09 | 9.38 | 63.94 | 61.73 | -10.29 | -2.06 | 2.56 | 2.54 | |||||||||
| Interest & Other Items | 0.06 | 0.24 | 0.77 | 1.60 | 0.74 | 0.45 | 0.49 | 1.21 | 1.22 | |||||||||
| PBT | 4.32 | 8.85 | 8.61 | 62.34 | 60.99 | -10.74 | -2.55 | 1.35 | 1.32 | |||||||||
| Taxes & Other Items | 1.21 | 2.61 | 2.22 | 15.96 | 16.02 | -2.49 | -0.75 | 0.49 | 0.51 | |||||||||
| Net Income | 3.11 | 6.24 | 6.39 | 46.38 | 44.97 | -8.25 | -1.80 | 0.86 | 0.81 | |||||||||
| EPS | 0.64 | 891.43 | 912.86 | 92.11 | 44.97 | -8.25 | -1.80 | 0.86 | 0.81 | |||||||||
| DPS | — | 0.00 | 0.00 | 2.00 | 3.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.02 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 |
NURECA Company Updates
NURECA Stock Peers
NURECA Past Performance & Peer Comparison
NURECA Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation-basic on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Nureca Ltd | 348.44 | 1.54 | — |
| Sun Pharmaceutical Industries Ltd | 36.65 | 5.53 | 0.96% |
| Cipla Ltd | 22.85 | 3.85 | 1.07% |
| Torrent Pharmaceuticals Ltd | 59.39 | 14.95 | 0.18% |
NURECA Stock Price Comparison
Compare NURECA with any stock or ETFCompare NURECA with any stock or ETF
NURECA
NURECA Holdings
NURECA Shareholdings
NURECA Promoter Holdings Trend
NURECA Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
NURECA Institutional Holdings Trend
NURECA Institutional Holdings Trend
Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has decreased by 3.12%
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
NURECA Shareholding Pattern
NURECA Shareholding Pattern
NURECA Shareholding History
NURECA Shareholding History
Foreign Institutions
smallcases containing NURECA stock
smallcases containing NURECA stock
Looks like this stock is not in any smallcase yet.
NURECA Events
NURECA Events
NURECA Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
NURECA Dividend Trend
No dividend trend available
NURECA Upcoming Dividends
NURECA Upcoming Dividends
No upcoming dividends are available
NURECA Past Dividends
NURECA Past Dividends
Cash Dividend
Ex DateEx DateFeb 24, 2022
Interim
Interim | Div/Share: ₹3.00
Dividend/Share
₹3.00
Ex DateEx Date
Feb 24, 2022
Cash Dividend
Ex DateEx DateSep 21, 2021
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Sep 21, 2021
NURECA Stock News & Opinions
NURECA Stock News & Opinions
Articles & Videos
Corporate
Nureca to conduct board meeting
Nureca will hold a meeting of the Board of Directors of the Company on 15 July 2025.Powered by Capital Market - Live
10 hours agoCapital Market - Live
Corporate
Nureca schedules AGM
Nureca announced that the 9th Annual General Meeting(AGM) of the company will be held on 16 June 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
Nureca reports consolidated net profit of Rs 2.47 crore in the March 2025 quarter
Net profit of Nureca reported to Rs 2.47 crore in the quarter ended March 2025 as against net loss of Rs 4.15 crore during the previous quarter ended March 2024. Sales rose 87.04% to Rs 31.74 crore in the quarter ended March 2025 as against Rs 16.97 crore during the previous quarter ended March 2024. For the full year,net profit reported to Rs 0.85 crore in the year ended March 2025 as against net loss of Rs 1.79 crore during the previous year ended March 2024. Sales rose 19.29% to Rs 109.66 crore in the year ended March 2025 as against Rs 91.93 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales31.7416.97 87 109.6691.93 19 OPM %3.78-26.10 --6.88-11.10 - PBDT2.57-5.87 LP 3.68-0.18 LP PBT2.05-6.47 LP 1.34-2.54 LP NP2.47-4.15 LP 0.85-1.79 LP Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Nureca to conduct board meeting
Nureca will hold a meeting of the Board of Directors of the Company on 5 May 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
Nureca reports consolidated net loss of Rs 2.80 crore in the December 2024 quarter
Net loss of Nureca reported to Rs 2.80 crore in the quarter ended December 2024 as against net profit of Rs 0.17 crore during the previous quarter ended December 2023. Sales rose 18.28% to Rs 26.46 crore in the quarter ended December 2024 as against Rs 22.37 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales26.4622.37 18 OPM %-15.19-19.00 - PBDT-2.711.54 PL PBT-3.250.95 PL NP-2.800.17 PL Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Nureca to convene board meeting
Nureca will hold a meeting of the Board of Directors of the Company on 24 January 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Nureca reports consolidated net loss of Rs 0.48 crore in the September 2024 quarter
Net loss of Nureca reported to Rs 0.48 crore in the quarter ended September 2024 as against net profit of Rs 2.89 crore during the previous quarter ended September 2023. Sales declined 0.51% to Rs 31.19 crore in the quarter ended September 2024 as against Rs 31.35 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales31.1931.35 -1 OPM %-7.574.40 - PBDT0.554.50 -88 PBT-0.083.91 PL NP-0.482.89 PL Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Nureca to declare Quarterly Result
Nureca will hold a meeting of the Board of Directors of the Company on 24 October 2024.Powered by Capital Market - Live
8 months agoCapital Market - Live
Nureca reports consolidated net profit of Rs 1.66 crore in the June 2024 quarter
11 months agoBusiness Standard
Earnings
Nureca reports consolidated net profit of Rs 1.66 crore in the June 2024 quarter
Net profit of Nureca reported to Rs 1.66 crore in the quarter ended June 2024 as against net loss of Rs 0.71 crore during the previous quarter ended June 2023. Sales declined 4.52% to Rs 20.27 crore in the quarter ended June 2024 as against Rs 21.23 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales20.2721.23 -5 OPM %-11.64-13.66 - PBDT3.28-0.35 LP PBT2.62-0.93 LP NP1.66-0.71 LP Powered by Capital Market - Live
11 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 4.18%, vs industry avg of 10.1%
Over the last 5 years, market share decreased from 0.04% to 0.03%
Over the last 5 years, net income has grown at a yearly rate of -33.04%, vs industry avg of 20.04%